The spectrum of morphology in non-neoplastic prostate including cancer mimics

Histopathology

Volumn 60, Issue 1, 2012, Pages 41-58

  Montironi, Rodolfo ^a   Scarpelli, Marina ^a   Mazzucchelli, Roberta ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Adenosis (atypical adenomatous hyperplasia); Atrophy; Basal cell hyperplasia; Clear cell cribriform hyperplasia; Prostate cancer; Prostate cancer mimics

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; PROSTATE SPECIFIC ANTIGEN;

ATYPICAL ADENOMATOUS HYPERPLASIA; BASAL CELL; BLOOD VESSEL INJURY; BRACHYTHERAPY; BREAST SCLEROSING ADENOSIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CELL INFILTRATION; CELL PROLIFERATION; CYTOLOGY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; EJACULATORY DUCT; EXTERNAL BEAM RADIOTHERAPY; FALSE POSITIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MITOSIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE DISEASE; PROSTATE EPITHELIUM; PROSTATECTOMY; PROSTATIC XANTHOMA; RADIATION ATYPIA; RADIATION DOSE; REVIEW; SEMINAL VESICLE; STROMA CELL; TRANSURETHRAL RESECTION; TREATMENT DURATION; TUMOR VOLUME; VERUMONTANUM MUCOSAL GLAND HYPERPLASIA;

HUMANS; MALE; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84255199229     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04000.x     Document Type: Review

References (47)

1. Hameed O, Humphrey PA. Pseudoneoplastic mimics of prostate and bladder carcinomas. Arch. Pathol. Lab. Med. 2010; 134; 427-443.
2. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod. Pathol. 2004; 17; 328-348.
3. Paner GP, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch. Pathol. Lab. Med. 2008; 132; 1388-1396.
4. De Marzo AM, Platz EA, Epstein JI et al. A working group classification of focal prostate atrophy lesions. Am. J. Surg. Pathol. 2006; 30; 1281-1291.
5. Brimo F, Epstein JI. Selected common diagnostic problems in urological pathology: perspectives from a large genitourinary pathology consult service. Arch. Pathol. Lab. Med. 2011 (in press).
6. Oppenheimer JR, Wills ML, Epstein JI. Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am. J. Surg. Pathol. 1998; 22; 440-445.
7. Cina SJ, Epstein JI. Adenocarcinoma of the prostate with atrophic features. Am. J. Surg. Pathol. 1997; 21; 289-295.
8. Bostwick DG, Srigley J, Grignon D et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well differentiated carcinoma. Hum. Pathol. 1993; 24; 819-832.
9. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in transurethral resections specimens. Am. J. Surg. Pathol. 1994; 18; 863-870.
10. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in needle biopsy specimens. Am. J. Surg. Pathol. 1995; 19; 737-747.
11. Goldstein NS, Qian J, Bostwick DG. Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum. Pathol. 1995; 26; 887-891.
12. Grignon DJ, Ro JY, Srigley JR, Troncoso P, Raymond AK, Ayala AG. Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. Am. J. Surg. Pathol. 1992; 16; 383-391.
13. Jones EC, Clement PB, Young RH. Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study. Am. J. Surg. Pathol. 1991; 15; 1171-1180.
14. Yang XJ, Wu CL, Woda BA et al. Expression of a-methylacyl-coA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am. J. Surg. Pathol. 2002; 26; 921-925.
15. Przybycin CG, Kunju LP, Wu AJ, Shah RB. Partial atrophy in prostate needle biopsies: a detailed analysis of its morphology, immunophenotype, and cellular kinetics. Am. J. Surg. Pathol. 2008; 32; 58-64.
16. Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res. 1998; 58; 389-391.
17. Doll JA, Zhu X, Furman J et al. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am. J. Pathol. 1999; 155; 967-971.
18. Herawi M, Parwani AV, Irie J, Epstein JI. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am. J. Surg. Pathol. 2005; 29; 874-880.
19. Berney DM, Fisher G, Kattan MW et al. Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome. Histopathology 2007; 51; 452-457.
20. Collina G, Botticelli AR, Martinelli AM, Fano RA, Trentini GP. Sclerosing adenosis of the prostate. Report of three cases with electronmicroscopy and immunohistochemical study. Histopathology 1992; 20; 505-510.
21. Cheng L, Bostwick DG. Atypical sclerosing adenosis of the prostate: a rare mimic of adenocarcinoma. Histopathology 2010; 56; 627-631.
22. Bostwick DG, Meiers I. Diagnosis of prostatic carcinoma after therapy. Arch. Pathol. Lab. Med. 2007; 131; 360-371.
23. Magi-Galluzzi C, Sanderson H, Epstein JI. Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: duration of atypia and relation to type of radiotherapy. Am. J. Surg. Pathol. 2003; 27; 206-212.
24. Yang XJ, Laven B, Tretiakova M et al. Detection of a-methylacylcoenzyme A racemase in postradiation prostatic adenocarcinoma. Urology 2003; 62; 282-286.
25. Gaudin PB, Wheeler TM, Epstein JI. Verumontanum mucosal gland hyperplasia in prostatic needle biopsy specimens: a mimic of low grade prostatic adenocarcinoma. Am. J. Clin. Pathol. 1995; 104; 620-626.
26. Amin MB, Bostwick DG. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. Mod. Pathol. 1996; 9; 791-795.
27. Bostwick DG, Qian J, Ma J, Muir TE. Mesonephric remnants of the prostate: incidence and histologic spectrum. Mod. Pathol. 2003; 16; 630-635.
28. Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin. Diagn. Pathol. 2005; 22; 88-104.
29. Rahemtullah A, Oliva E. Nephrogenic adenoma: an update on an innocuous but troublesome entity. Adv. Anat. Pathol. 2006; 13; 247-255.
30. Tong GX, Melamed J, Mansukhani M et al. PAX2: a reliable marker for nephrogenic adenoma. Mod. Pathol. 2006; 19; 356-363.
31. Tong GX, Weeden EM, Hamele-Bena D et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis? Am. J. Surg. Pathol. 2008; 32; 1380-1387.
32. Cheng L, Cheville JC, Sebo TJ, Eble JN, Bostwick DG. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer 2000; 88; 853-861.
33. Grignon DJ, O'Malley FP. Mucinous metaplasia in the prostate gland. Am. J. Surg. Pathol. 1993; 17; 287-290.
34. Saboorian MH, Huffman H, Ashfaq R, Ayala AG, Ro JY. Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate. Immunohistochemical and ultrastructural studies. Am. J. Surg. Pathol. 1997; 21; 1069-1074.
35. Schowinsky JT, Epstein JI. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer. Am. J. Surg. Pathol. 2006; 30; 866-870.
36. Montironi R, Mazzucchelli R, Stramazzotti D et al. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. J. Clin. Pathol. 2005; 58; 290-296.
37. Yang XJ, Tretiakova MS, Sengupta E, Gong C, Jiang Z. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis. Hum. Pathol. 2003; 34; 462-470.
38. Frauenhoffer EE, Ro JY, El-Naggar AK, Ordonez NG, Ayala AG. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. Am. J. Clin. Pathol. 1991; 95; 446-453.
39. Humphrey PA, Kaleem Z, Swanson PE, Vollmer RT. Pseudohyperplastic prostatic adenocarcinoma. Am. J. Surg. Pathol. 1998; 22; 1239-1246.
40. Levi AW, Epstein JI. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am. J. Surg. Pathol. 2000; 24; 1039-1046.
41. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of amethylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am. J. Surg. Pathol. 2003; 27; 772-778.
42. Milord RA, Kahane H, Epstein JI. Infarct of the prostate gland: experience on needle biopsy specimens. Am. J. Surg. Pathol. 2000; 24; 1378-1384.
43. Speights VO, Brawn PN. Serum prostate specific antigen levels in non-specific granulomatous prostatitis. Br. J. Urol. 1996; 77; 408-410.
44. Alguacil-Garcia A. Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens. Am. J. Surg. Pathol. 1986; 10; 795-800.
45. Wang HL, Humphrey PA. Exaggerated signet-ring cell change in stromal nodule of prostate: a pseudoneoplastic proliferation. Am. J. Surg. Pathol. 2002; 26; 1066-1070.
46. Chuang AY, Epstein JI. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma. Am. J. Surg. Pathol. 2007; 31; 1225-1230.
47. Howarth SM, Griffiths DF, Varma M. Paraganglion of the prostate gland: an uncommon mimic of prostate cancer in needle biopsies. Histopathology 2005; 47; 114-115.